UNITED THERAPEUTICS ($UTHR) is expected to release its quarterly earnings data on Wednesday, February 26th before market open, per Finnhub. Analysts are expecting revenue of $749,435,167 and earnings of $6.44 per share.
You can see Quiver Quantitative's $UTHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UNITED THERAPEUTICS Insider Trading Activity
UNITED THERAPEUTICS insiders have traded $UTHR stock on the open market 271 times in the past 6 months. Of those trades, 0 have been purchases and 271 have been sales.
Here’s a breakdown of recent trading of $UTHR stock by insiders over the last 6 months:
- MICHAEL BENKOWITZ (PRESIDENT AND COO) has made 0 purchases and 183 sales selling 174,700 shares for an estimated $65,209,517.
- JAMES EDGEMOND (CFO AND TREASURER) has made 0 purchases and 44 sales selling 85,730 shares for an estimated $30,469,001.
- LOUIS W SULLIVAN has made 0 purchases and 24 sales selling 26,209 shares for an estimated $9,781,714.
- PAUL A MAHON (EVP & GENERAL COUNSEL) has made 0 purchases and 2 sales selling 15,400 shares for an estimated $5,711,321.
- RICHARD GILTNER has made 0 purchases and 2 sales selling 10,000 shares for an estimated $3,817,022.
- CHRISTOPHER PATUSKY has made 0 purchases and 8 sales selling 10,000 shares for an estimated $3,579,719.
- JUDY D. OLIAN sold 1,750 shares for an estimated $721,840
- CHRISTOPHER CAUSEY sold 510 shares for an estimated $192,080
- NILDA MESA has made 0 purchases and 2 sales selling 479 shares for an estimated $183,070.
- MARTINE A ROTHBLATT (Chairperson & CEO) has made 0 purchases and 4 sales selling 269 shares for an estimated $93,722.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UNITED THERAPEUTICS Hedge Fund Activity
We have seen 346 institutional investors add shares of UNITED THERAPEUTICS stock to their portfolio, and 281 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WEALTHFRONT ADVISERS LLC added 18,313,424 shares (+2090573.5%) to their portfolio in Q4 2024, for an estimated $6,461,708,524
- WELLINGTON MANAGEMENT GROUP LLP removed 706,958 shares (-22.3%) from their portfolio in Q4 2024, for an estimated $249,443,060
- FMR LLC added 393,777 shares (+36.5%) to their portfolio in Q4 2024, for an estimated $138,940,276
- NORGES BANK added 391,191 shares (+1004.8%) to their portfolio in Q4 2024, for an estimated $138,027,832
- THRIVENT FINANCIAL FOR LUTHERANS added 189,967 shares (+1325.5%) to their portfolio in Q4 2024, for an estimated $67,027,956
- AUSTRALIANSUPER PTY LTD added 161,751 shares (+577.1%) to their portfolio in Q4 2024, for an estimated $57,072,222
- ALLIANCEBERNSTEIN L.P. added 157,363 shares (+28.5%) to their portfolio in Q4 2024, for an estimated $55,523,960
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UNITED THERAPEUTICS Government Contracts
We have seen $1,959,960 of award payments to $UTHR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TYVASO: $264,485
- TYVASO: $191,017
- TYVASO 0.6MG/ML SOLN, INHL, REFILL KIT X9 NDC: 66302-0206-02: $132,242
- BULK ORDER TYVASO: $89,934
- TYVASO: $88,161
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
